Seres Therapeutics OverviewSeres Therapeutics EBIT
EBIT (Earnings Before Interest and Taxes) analysis for MCRB.
Quarterly EBIT
-$21.69M
↑ 20.37% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$83.40M
↑ 21.31% YoY
Trailing 12 months ending Mar 31, 2026
Seres Therapeutics OverviewEBIT (Earnings Before Interest and Taxes) analysis for MCRB.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026